GC Biopharma will acquire ABO Holdings for $96 million to enhance its immunoglobulin medication Alyglo's supply chain.
On election day, Tuesday, November 5, Americans will choose between former President Donald Trump and current Vice President ...
"They look forward to vigorously litigating these matters in a public forum in the coming weeks and months," said Evan Gotlob ...
The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...
Morgan Stanley lowered the firm’s price target on Zenas BioPharma (ZBIO) to $35 from $40 and keeps an Overweight rating on the shares. The firm ...
Biopharma leaders at companies developing blood cancer therapies say we shouldn’t be afraid to use the four-letter word: cure ...
1d
Analyst Reni Benjamin of JMP Securities reiterated a Buy rating on Sutro Biopharma (STRO – Research Report), retaining the price target of ...
Veradermics Inc., a New Haven-based biopharmaceutical company, said Wednesday it has closed a $75 million Series B financing ...
Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...
With the China-targeting Biosecure Act absent from a key defense spending bill revealed over the weekend, it appears the ...
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...
ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company advancing therapeutic solutions in ophthalmology, CNS (central nervous system), and oncology/hematology, announced the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback